Alkem Laboratories board meeting scheduled for May 28, 2026 to approve Q4 and FY26 audited financial results.
Board to consider recommendation of final dividend for financial year ended March 31, 2026.
Disclosure made under SEBI LODR Regulations 29 and 33 for mandatory exchange communication.